Brain water changes after clot-busting drug for stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at how much water builds up in brain tissue after a stroke is treated with a clot-busting drug. It may help doctors understand who will recover better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke caused by a clot (ischemic stroke) and received a clot-busting drug (intravenous thrombolysis).
- A CT scan of your head was done when you arrived at the hospital.
- Another CT or MRI scan was done 12 to 24 hours after the clot-busting treatment.
- The final size of your stroke was more than 5 milliliters.
- Your doctors used a scoring system called ASPECTS to evaluate your CT scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a clot-dissolving medicine (alteplase or tenecteplase) is safe and effective for people who have had a stroke and are taking a blood thinner (DOAC) like apixaban or rivaroxaban. It aims to see if this treatment can still be given within a few hours of the stroke.
This study looks at whether giving a clot-busting medicine (IV thrombolysis) is safe and effective for people who have had a stroke and also recently took a direct oral anticoagulant (DOAC). If you've taken a DOAC in the last 48 hours, this trial may help doctors decide the best treatment for you.
This study looks at inflammation signals in the body and in brain MRI scans after treatment to reopen a blocked brain artery. It may help researchers understand who benefits most from different “reperfusion” treatments like clot-busting medicine or procedures.
This trial looks at how blood flow and brain activity change in the first days after a stroke caused by a large blockage in the front part of the brain. It tests if certain patterns can help predict recovery after a procedure to remove the clot.
This study tests whether giving a clot-busting medicine through an IV can help people who have had a stroke while taking a common blood thinner (apixaban, dabigatran, edoxaban, or rivaroxaban). It may be an option if your last dose of the blood thinner was 12 to 48 hours before the stroke and you arrive at the hospital within 4.5 hours of symptoms starting.
This study tests if giving a simple saline (salt water) drip after the standard clot-busting medicine helps improve recovery in people who had a stroke from a clot. It may be a safe, low-cost way to support brain healing.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.